Geneva Capital Management’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-238,544
Closed -$15.7M 126
2023
Q1
$15.7M Buy
238,544
+14,203
+6% +$878K 0.32% 85
2022
Q4
$10.1M Sell
224,341
-30,063
-12% -$1.63M 0.23% 91
2022
Q3
$18.4M Sell
254,404
-13,727
-5% -$1.36M 0.43% 84
2022
Q2
$28.8M Sell
268,131
-3,611
-1% -$368K 0.66% 60
2022
Q1
$30.1M Sell
271,742
-13,395
-5% -$1.4M 0.58% 73
2021
Q4
$36.5M Buy
285,137
+53,008
+23% +$6.81M 0.59% 71
2021
Q3
$30.9M Sell
232,129
-12,869
-5% -$1.61M 0.52% 80
2021
Q2
$26.5M Sell
244,998
-11,712
-5% -$1.26M 0.43% 88
2021
Q1
$27M Buy
256,710
+26,625
+12% +$2.97M 0.46% 84
2020
Q4
$23.9M Buy
230,085
+24,728
+12% +$2.4M 0.41% 87
2020
Q3
$17.6M Buy
+205,357
New +$17.4M 0.36% 91

Other funds holding CTLT

Geneva Capital Management's CTLT Position: Q2 2023 in Review

Geneva Capital Management sold out of CATALENT, INC. (CTLT) in Q2 2023, closing a stake of 238,544 shares — an estimated $15.7M sold.

Geneva Capital Management first reported a position in CTLT in Q3 2020 and held it in 11 quarters. The position peaked at $36.5M in Q4 2021. 441 funds tracked by Wall St. Rank hold CTLT as of Q2 2023.

  • Geneva Capital Management reported no remaining CATALENT, INC. position as of Q2 2023 after selling out during the quarter.
  • Geneva Capital Management sold 238,544 CATALENT, INC. shares in Q2 2023, an estimated $15.7M.
  • Geneva Capital Management first reported a position in CATALENT, INC. in Q3 2020 and held it in 11 quarters.
  • Geneva Capital Management's CATALENT, INC. position peaked at $36.5M in Q4 2021.
  • 441 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2023.

Based on Geneva Capital Management's 13F filing for Q2 2023, filed 1 Aug 2023.